*RUSM has a first-time residency attainment rate of 96%, calculated as the percent of students attaining a 2025-26 residency position out of graduates or expected graduates in 2024-25 who were active applicants in the 2025 NRMP match or who attained a residency position outside the NRMP match. AUC’s first-time residency attainment rate for 2024-2025 graduates and expected graduates is 95%. SABA’s four-year residency placement rate of 97% is calculated as the percent of students attaining a residency position out of all graduates or expected graduates in 2020-21, 2021-22, 2022-23 and 2023-24 who were active applicants in the NRMP match or attained a residency outside the NRMP match. As of July 17, 2025, they have not published their 2025 rates. SGU’s US residency placement rate of 94% pertains to graduates over five years from 2021, 2022, 2023, 2024, and 2025 with the rate calculated as the total number of students/graduates who obtained a US residency divided by the total number of students/graduates who applied to a US residency program in a given year as of April 2025.
Ross University School of Medicine's First Annual Convocation
Get Started Today
You'll submit your completed Ross Med application online in our application portal.
The ceremony provides a forum to reflect and recognize RUSM’s extraordinary past successes, future opportunities in the years ahead, and reaffirms the continuing vitality of the Ross University School of Medicine community. All members of RUSM’s family are welcome and will be celebrated during the event, including colleagues, faculty, students and alumni.
CONVOCATION SPEAKER: This year’s convocation message will be delivered by Dr. Griffin Rodgers. Dr. Rodgers is the Director of the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of Health, where he provides scientific leadership and manages a staff of over 600 employees and a budget of over $2.0 billion. Dr. Rodgers received his undergraduate, graduate, and medical degrees from Brown University, and performed his residency and chief residency in internal medicine at Barnes Hospital and the Washington University School of Medicine. His fellowship training in hematology was in a joint program of the NIH with George Washington University and the Washington Veterans Administration Medical Center. In addition, he earned an MBA, with a focus on the business of medicine/science, from The Johns Hopkins University. As a research investigator, Dr. Rodgers is widely recognized for his contributions to the development of the first effective—and FDA approved—therapy for sickle cell anemia. He was a principal investigator in clinical trials to develop therapy for patients with sickle cell disease and also performed basic research that focused on understanding the molecular basis of how certain drugs induce gamma-globin gene expression. More recently, he and his collaborators have reported on a modified blood stem-cell transplant regimen that is highly effective in reversing sickle cell disease in adults, and is associated with relatively low toxicity.
The 2018 Convocation ceremony is from 10 am-12 pm EST on Saturday, October 20 at Bijou Theatre in Knoxville, TN. St. Kitts colleagues will join via livestream.
The information and material contained in this article and on this website are for informational purposes only and should not be considered, or used in place of, professional medical advice. Please speak with a licensed medical provider for specific questions or concerns. Ross Med is not responsible for the information maintained or provided on third-party websites or external links.